Negative hearing effects of a single course of IV aminoglycoside therapy in cystic fibrosis patients-Reference-Cited by-同舟云学术

Negative hearing effects of a single course of IV aminoglycoside therapy in cystic fibrosis patients

Published:2018-11-01 Issue:12 Volume:57 Page:923-930
ISSN:1499-2027
Container-title:International Journal of Audiology
language:en
Short-container-title:International Journal of Audiology

Author:

Gleser Malcolm A.¹,Zettner Erika M.²

Affiliation:

1. CEO Oricula Therapeutics LLC, Seattle, WA, USA;

2. Department of Surgery, University of California San Diego, La Jolla, CA, USA

Funder

Institutional Review Board for Human Subjects

Publisher

Informa UK Limited

Subject

Speech and Hearing,Linguistics and Language,Language and Linguistics

Link

https://www.tandfonline.com/doi/pdf/10.1080/14992027.2018.1514537

Reference19 articles.

1. High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis

2. Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions

3. American Speech-Language-Hearing Association (ASHA). 1994. Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. 36(suppl 12): 11–19.

4. Toxicodynamics and toxicokinetics of amikacin in the guinea pig cochlea

5. Preferred Method For Clinical Determination Of Pure-Tone Thresholds

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Observations in Patients With Cystic Fibrosis–Related Diabetes and Self-Reported Ototoxicity Symptoms;American Journal of Audiology;2023-11-28

2. Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations;International Forum of Allergy & Rhinology;2022-02-22

3. A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment;American Journal of Respiratory and Critical Care Medicine;2021-12-01

4. Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation;Journal of Cystic Fibrosis;2021-03

5. Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin;Journal of Cystic Fibrosis;2021-03